OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD)

2010 ◽  
Vol 20 ◽  
pp. S37-S38
Author(s):  
P.H. Saenger ◽  
V. Khadilkar ◽  
K.A. Radjuk ◽  
E. Bolshova ◽  
R. Khadgawat ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Endogenous Growth ◽  
Growth Failure ◽  
Prolonged Release ◽  
Release Formulation ◽  
Rhgh Therapy ◽  
Safety And Efficacy ◽  
Treatment Naïve

SAFETY AND EFFICACY OF GROWTH HORMONE IN CHILDREN WITH GROWTH FAILURE AFTER CARDIAC TRANSPLANTATION.

1999 ◽  
Vol 67 (7) ◽  
pp. S180
Author(s):  
B. Softness ◽  
G. S. Aranoff ◽  
D. T. Hsu ◽  
A. R. Murphy ◽  
J. F. Douglas ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Cardiac Transplantation ◽  
Growth Failure ◽  
Safety And Efficacy

scholarly journals Safety and Efficacy of Human Growth Hormone (rhGH) in Children with Growth Failure after Cardiac Transplantation

1999 ◽  
Vol 45 (4, Part 2 of 2) ◽  
pp. 31A-31A
Author(s):  
B Softness ◽  
G S Aranoff ◽  
D T Hsu ◽  
A R Murphy ◽  
J F Douglas ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Human Growth Hormone ◽  
Cardiac Transplantation ◽  
Growth Failure ◽  
Human Growth ◽  
Safety And Efficacy

Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegaly

2013 ◽  
Vol 80 (1) ◽  
pp. 92-100 ◽  
Author(s):  
Michael Madsen ◽  
Sanne Fisker ◽  
Ulla Feldt-Rasmussen ◽  
Mikkel Andreassen ◽  
Lars Østergaard Kristensen ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Endogenous Growth ◽  
Circulating Levels
Sign in / Sign up

Export Citation Format

Share Document